IL10 and neoplasm: Conversely, IL-10 and IL-12 have been verified to reduce the phosphorylation of the STAT5 gene in NK cells, contributing to tumor progression by increasing the production of VEGF-A protein and subsequent vascular endothelial growth (Gotthardt et al., 2016).